ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,015.54
-0.40%
Dow Jones
37,913.40
0.26%
US Dollar vs MXN
17.02144
-0.77%
Brent Oil
83.555
-2.72%
Bitcoin
56,761.29
-6.33%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Map Pharmaceuticals, Inc. (MM) (MAPP)

  7. Map Pharmaceuticals, Inc. (MM) (MAPP) Noticias

MAPP

Map Pharmaceuticals, Inc. (MM) (MAPP)

Map Pharmaceuticals, Inc. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MAPP
FechaHoraFuenteTítuloSímboloCompañía
05/03/201311:38ZacksAllergan Reaches 52-Week High - Analyst BlogNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
04/03/201310:30ZacksAllergan - MAP Acquisition Update - Analyst BlogNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201316:23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201316:23Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201316:21Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201315:01Edgar (US Regulatory)(25-NSE)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201314:54Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201314:54Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/03/201308:00Business WireAllergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. & Intent to Exerc...NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
14/02/201313:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
14/02/201312:48Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
07/02/201308:00Business WireAllergan, Inc. & MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early Termination of Waiting Per...NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
05/02/201313:22Dow Jones NewsUPDATE: Strong Botox Sales Help Lift Allergan's Profits 16%NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
05/02/201310:28ZacksAGN Earnings Miss but Guidance Tops - Analyst BlogNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
05/02/201309:00Dow Jones NewsAllergan 4th-Quarter Profit Rose 16% Amid Growing Revenue, Fewer ChargesNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
04/02/201317:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/02/201312:08GlobeNewswire Inc.The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP PharmaceutNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
01/02/201310:50ZacksUpdate on AGN's Acquisition of MAP - Analyst BlogNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
31/01/201315:20Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
31/01/201315:01Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
31/01/201315:01Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
31/01/201308:20PR Newswire (US)Pharmaceutical Company Achieves Positive In-Vitro Testing Results Diabetes DrugNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
31/01/201308:00Business WireAllergan Commences Cash Tender Offer for All Outstanding Shares of MAP PharmaceuticalsNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
30/01/201315:03Edgar (US Regulatory)(40-17F2)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
30/01/201315:03Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
30/01/201310:04Business WireFaruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of MAP Pharmaceuticals, Inc. (MAPP)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
30/01/201309:48PR Newswire (US)Morgan & Morgan Announces Investigation of MAP Pharmaceuticals (NASDAQ: MAPP)NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
29/01/201312:50ZacksFavorable Ruling for Allergan - Analyst BlogNASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
26/01/201311:00Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
25/01/201314:41PR Newswire (US)The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmace...NASDAQ:MAPPMap Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:MAPP

Su Consulta Reciente

FX
EURMXN
Euro vs MXN
CCOM
US500
US 500
NYSE
MCD
McDonalds
USOTC
ADDYY
Adidas (QX)
AMEX
XLF
Financial Select Sector
NYSE
MRK
Merck
NYSE
VZ
Verizon Communications
SPI
SP500
S&P 500
FX
EURUSD
Euro vs US Dollar
NYSE
BAC
Bank of America
NASDAQ
TSLA
Tesla
NASDAQ
GOOGL
Alphabet
COIN
BTCUSD
Bitcoin
COIN
ETHUSD
Ethereum
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados